MannKind Corporation (MNKD) NASDAQ
2.79
+0.16(+6.08%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.79
+0.16(+6.08%)
Currency In USD
| Previous Close | 2.63 |
| Open | 2.67 |
| Day High | 2.81 |
| Day Low | 2.66 |
| 52-Week High | 6.51 |
| 52-Week Low | 2.23 |
| Volume | 5.45M |
| Average Volume | 5.73M |
| Market Cap | 861.54M |
| PE | 139.5 |
| EPS | 0.02 |
| Moving Average 50 Days | 3.03 |
| Moving Average 200 Days | 4.63 |
| Change | 0.16 |
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
GlobeNewswire Inc.
Mar 09, 2026 1:05 PM GMT
Presentations highlight real‑world dosing and titration patterns in youth, and post‑prandial glucose management strategies using inhaled insulin in both adults and youth with T1DData to be featured across oral and poster sessions at the Advanced Tech
MannKind Announces Settlement of Convertible Senior Notes
GlobeNewswire Inc.
Mar 05, 2026 9:30 PM GMT
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced the settlement of the remaining $36.3 million aggregate principal amount of 2.50% convertible senior notes, all of w
MannKind to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Mar 04, 2026 2:00 PM GMT
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today its attendance at two upcoming investor conferences, at which MannKind’s Chief Executive Officer, Michael Castagna,